Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monoclonal T-Cell Receptors: New Reagents for Cancer Therapy

19 Jun 2007

Abstract excerpt

Adoptive transfer of antigen-specific T lymphocytes is an effective form of immunotherapy for persistent virus infections and cancer. A major limitation of adoptive therapy is the inability to isolate antigen-specific T lymphocytes reproducibly. The demonstration that cloned T-cell receptor (TCR) genes can be used to produce T lymphocyte populations of desired specificity offers new opportunities for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Cytomegalovirus and herpesvirus research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17637721
DOI: 10.1038/sj.mt.6300216

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monoclonal T-Cell Receptors: New Reagents for Cancer TherapyPMID 17637721Read ↗

Challenges in T cell receptor gene therapySemantic proximity Read ↗

T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistanceSemantic proximity Read ↗

Adoptive immunotherapy for cancer: the next generation of gene‐engineered immune cellsSemantic proximity Read ↗

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenSemantic proximity Read ↗

Clinical application of genetically modified T cells in cancer therapySemantic proximity Read ↗

Design and implementation of adoptive therapy with chimeric antigen receptor‐modified T cellsSemantic proximity Read ↗

The Anticancer Potential of T Cell Receptor-Engineered T Cells.Semantic proximity Read ↗

Adoptive Cell TherapySemantic proximity Read ↗

Chimeric Antigen Receptors: A Paradigm Shift in ImmunotherapySemantic proximity Read ↗

Chimeric Antigen Receptors Modified T-Cells for Cancer TherapySemantic proximity Read ↗

T Cell Receptor Gene Therapy for CancerSemantic proximity Read ↗

Biology-based AI Predicts T-cell Receptor Antigen Binding SpecificitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.